Literature DB >> 30665927

Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A.

Weibin Shi1,2, Shannon Schultz1,2, Amy Strouse1,2, David R Gater1,2.   

Abstract

A 41-year-old obese Native American woman presented with hidradenitis suppurativa (HS) after failing all available treatment options. Her HS was more pronounced in the axillary and groin regions (Hurley stage III) and was a major source of her pain and a barrier for home exercise and aquatic therapy. She received a botulinum toxin A injection every 3 months (four times thus far), which has significantly helped alleviate her pain and curb the progress of her HS by resolving abscesses and healing draining sinuses. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dermatology; pain; skin

Mesh:

Substances:

Year:  2019        PMID: 30665927      PMCID: PMC6340567          DOI: 10.1136/bcr-2018-226064

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Treatment of hidradenitis suppurativa with botulinum toxin A.

Authors:  David J O'Reilly; Jonathon M Pleat; Adrian M Richards
Journal:  Plast Reconstr Surg       Date:  2005-10       Impact factor: 4.730

2.  Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A.

Authors:  Marta Feito-Rodríguez; Elena Sendagorta-Cudós; Pedro Herranz-Pinto; Raul de Lucas-Laguna
Journal:  Dermatol Surg       Date:  2009-06-03       Impact factor: 3.398

3.  Hidradenitis suppurativa treated with Clostridium botulinum toxin A.

Authors:  A B S Khoo; E P Burova
Journal:  Clin Exp Dermatol       Date:  2014-07-01       Impact factor: 3.470

4.  Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions.

Authors:  H H van der Zee; L de Ruiter; J Boer; D G van den Broecke; J C den Hollander; J D Laman; E P Prens
Journal:  Br J Dermatol       Date:  2011-12-05       Impact factor: 9.302

5.  Botulinum toxin A for axillary hyperhidrosis (excessive sweating).

Authors:  M Heckmann; A O Ceballos-Baumann; G Plewig
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

6.  Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands.

Authors:  C C Yu; M G Cook
Journal:  Br J Dermatol       Date:  1990-06       Impact factor: 9.302

Review 7.  Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.

Authors:  Maddalena Napolitano; Matteo Megna; Elena A Timoshchuk; Cataldo Patruno; Nicola Balato; Gabriella Fabbrocini; Giuseppe Monfrecola
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-19
  7 in total
  4 in total

Review 1.  Botulinum toxin type A for the management of hidradenitis suppurativa.

Authors:  Huanhuan Qu; Lin Gao
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 2.  Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.

Authors:  Marius Nicolae Popescu; Cristina Beiu; Mădălina Gabriela Iliescu; Mara Mădălina Mihai; Liliana Gabriela Popa; Ana Maria Alexandra Stănescu; Mihai Berteanu
Journal:  Medicina (Kaunas)       Date:  2022-06-16       Impact factor: 2.948

Review 3.  Off-Label Use of Botulinum Toxin in Dermatology-Current State of the Art.

Authors:  Miłosz Lewandowski; Zuzanna Świerczewska; Wioletta Barańska-Rybak
Journal:  Molecules       Date:  2022-05-13       Impact factor: 4.927

4.  Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review.

Authors:  Emanuela Martina; Federico Diotallevi; Giulia Radi; Anna Campanati; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2021-02-05       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.